¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"total renal plasma flow"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® total lung capacity ÇÑ±Û ÀüÆó¿ë·®, ¿ÂÇãÆÄ¿ë·®
¼³¸í   
  ÆóȰ·®(°¡´ÉÇÑ ÇÑ ±í°Ô µé¿© ¸¶½Å ½ÃÁ¡ºÎÅ͠õõÈ÷ ÇѲ¯ ³»½® ¿ë·®)¿¡ Àܱⷮ(ÃÖ´ë ³¯¼ûÀ§Ä¡¿¡¼­ Æó³»¿¡ ³²Àº ¿ë·®. ¾à 1,200mL)À» ÇÕÇÑ °ÍÀÌ´Ù. °Ç°­ÇÑ ¼ºÀÎÀº 6,000~7,000mL. Æó±âÁ¾, ¸¸¼º ±â°üÁö¿° µîÀÇ Æó»ö¼º Àå¾Ö·Î Áõ°¡ÇϰԠµÇ´Â ÇÑÆí ÇãÆÄ¼¶À¯Áõ, ¹«±âÆó, Èä¼ö, Èä°ûº¯Çü µîÀÇ ±¸¼Ó¼º Àå¾Ö·Î °¨¼ÒÇÑ´Ù.
¿µ¹® flow ÇÑ±Û È帧, À¯·®
¼³¸í   
  ¾×ü ¶Ç´Â ±âüÀÇ °¢ ºÎºÐÀÌ ½Ã°£°ú ÇÔ²² ¿¬¼ÓÀûÀ¸·Î ±× À§Ä¡¸¦ À̵¿Çϴ Çö»ó. ±× ¾ç»óÀº º¹ÀâÇÏÁö¸¸ °¢ Á¡¿¡¼­ÀÇ È帧ÀÇ ¹æÇâÀÌ ±× Á¡¿¡¼­ÀÇ Á¢¼± ¹æÇâ°ú ÀÏÄ¡Çϵµ·Ï ¼±À» ±×À¸¸é È帧ÀÇ ¸ð¾çÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ°Ô µÈ´Ù.
¿µ¹® plasma ÇÑ±Û Ç÷Àå
¼³¸í   
  Ç÷¾×À̳ª ¸²ÇÁ¾×ÀÇ ¾×ü ºÎºÐÀ» ¸»Çϴµ¥, ÁַΠÇ÷¾×¿¡¼­ °íÇü¼ººÐ(Ç÷±¸¼¼Æ÷)À» Á¦¿ÜÇÑ ¾×ü ºÎºÐÀ» ÀǹÌÇÑ´Ù. ¿©±â¿¡´Â ´Ü¹é¼ººÐ(¸é¿ªÇö»óÀ» À¯¹ßÇϴ Ç×ü¸¦ Æ÷ÇÔÇÔ), ¿µ¾ç¼ººÐ(°¢ ¼¼Æ÷¿¡ ¿µ¾çºÐÀ» °ø±ÞÇÔ), ±×¸®°í Ç÷¾×ÀÀ°í ¼ººÐ(»óó°¡ ³µÀ» ¶§ ÃâÇ÷ÀÌ ¸ÜÀ» ¼ö ÀÖµµ·Ï ÇÔ) µîÀÌ Æ÷ÇԵȴÙ.
¿µ¹® plasma membrane ÇÑ±Û ÇüÁú¸·
¼³¸í   
  ¿øÇüÁú Ç¥¸éÀ» µ¤´Â ¿¯Àº¸·. µÎ²²´Â 5~25¥ìmÀÌ´Ù. ±¤ÇÐÇö¹Ì°æÀ¸·Î´Â °üÂûÇÒ ¼ö ¾øÁö¸¸ ÀüÀÚÇö¹Ì°æÀ¸·Î °üÂûÀÌ °¡´ÉÇÏ´Ù. ¿øÇüÁú¸·ÀÇ ºÐÀÚ±¸Á¶´Â ·¹½ÃƾÀ̳ª ÄÝ·¹½ºÅ×·Ñ µîÀǠǥ¸é È°¼º¹°Áú ºÐÀÚ°¡ 2ºÐÀÚÃþÀ¸·Î ±× Ç¥¸é¿¡ ¹è¿­µÇ¸ç, À̰ÍÀ» °¢ 1ºÐÀÚÃþÀÇ ´Ü¹éÁú ºÐÀÚ°¡ ¾çÂÊ¿¡¼­ »÷µåÀ§Ä¡ÇÑ ´ÜÀ§¸· ±¸Á¶ÀÌ´Ù. ÀüÀÚÇö¹Ì°æÀûÀ¸·Î ÀÌ ´ÜÀ§´Â ¾Ï-¸í-¾ÏÀÇ 3Ãþ(°¢ ¾à 20nm)À¸·Î ±¸º°µÈ´Ù. ¿øÇüÁúÀÇ Åõ°ú¼º¿¡ Áß¿äÇÑ ±¸½ÇÀ» Çϸç, »ý¸®»óŰ¡ º¯Çϸ頱נÅõ°ú¼ºµµ ½Å¼ÓÈ÷ º¯ÇÑ´Ù. ¶Ç, ¼Õ»óÀÌ µÇ¸é ½±°Ô »õ·Î Çü¼ºµÈ´Ù.
¿µ¹® renal biopsy ÇÑ±Û ÄáÆÏ»ý°Ë
¼³¸í   
  ÄáÆÏÀÇ º´º¯ÀÌ Àǽɵɠ¶§ È®ÁøÀ» À§ÇØ ÁÖ»ç¹Ù´Ã µîÀ» ÀÌ¿ëÇÏ¿© ÄáÆÏÁ¶Á÷À» ÀϺΠ¶¼¾î³»¼­ Çö¹Ì°æÀ¸·Î °Ë°æÇϴ °Í.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷ÀåÀ¯·®, À¯È¿½ÅÀåÇ÷ÀåÀ¯·®
  • extended radical total gastrectomy
    È®´ë±ÙÄ¡ÀüüÀ§ÀýÁ¦(¼ú)
  • radical total gastrectomy
    ±ÙÄ¡ÀüüÀ§ÀýÁ¦(¼ú)
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®, À¯È¿½ÅÀåÇ÷·ù·®
  • antihemophilic human plasma
    Ç×Ç÷¿ìº´Ç÷Àå
  • blood plasma
    Ç÷Àå
  • fresh frozen plasma
    ½Å¼±³Ãµ¿Ç÷Àå
  • human plasma protein fraction
    »ç¶÷Ç÷Àå´Ü¹éºÐÀ²
  • interstitial plasma cell pneumonia
    »çÀÌÁúÇüÁú¼¼Æ÷Æó·Å, ÆóÆ÷ÀÚÃæÁõ
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
  • plasma
    1. Ç÷Àå 2. ¿øÇüÁú, ¼¼Æ÷Áú
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷Áúȯ
  • plasma cell granuloma
    ÇüÁú¼¼Æ÷À°¾ÆÁ¾
  • plasma cell mastitis
    ÇüÁú¼¼Æ÷À¯¹æ¿°
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • flow cytometry
    È帧¼¼Æ÷ÃøÁ¤
  • flow
    1.È帧, 2.À¯·®
  • blood flow
    Ç÷·ù
  • blood flow rate
    Ç÷·ù·®, Ç÷·ù¼Óµµ
  • peak expiratory flow rate
    ÃÖ°í³¯¼û¼Óµµ, ÃÖ°íÈ£±âÀ¯¼Ó
  • blood flow velocity
    ÇÇÈ帧¼Óµµ, Ç÷·ù¼Óµµ
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma expander
    Ç÷ÀåÁõ·®Á¦
  • plasma exchange
    Ç÷À屳ȯ(¼ú)
  • plasma volume expander
    ÀΰøÇ÷ÀåÁõ·®Á¦
  • plasma membrane
    ÇüÁú¸·
  • plasma
    1. Ç÷Àå, 2. ¿øÇüÁú, ¼¼Æ÷Áú
  • fresh frozen plasma
    ½Å¼±³Ãµ¿Ç÷Àå
  • total androgen
    ÃѾȵå·Î°Õ
  • total iron binding capacity
    ÃÑö°áÇÕ´É
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective renal plasma flow
    À¯È¿ÄáÆÏÇ÷Àå·ù·®
  • effective renal blood flow
    À¯È¿ÄáÆÏÇ÷·ù·®
  • antihemophilic plasma
    Ç×Ç÷¿ìº´Ç÷Àå
  • blood plasma
    Ç÷Àå
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma coagulase
    Ç÷ÀåÀÀ°íÈ¿¼Ò
  • thromboplastin plasma component
    Æ®·Òº¸ÇÃ¶ó½ºÆ¾Ç÷À强ºÐ
  • plasma cell dyscrasia
    ÇüÁú¼¼Æ÷Áúȯ
  • plasma exchange
    Ç÷À屳ȯ, Ç÷À屳ȯ¼ú
  • plasma volume expander
    ÀΰøÇ÷ÀåÁõ·®Á¦
  • plasma coagulation factor
    Ç÷ÀåÀÀ°íÀÎÀÚ
  • plasma thromboplastin factor
    Ç÷À寮·Òº¸ÇÃ¶ó½ºÆ¾ÀÎÀÚ
  • plasma cell granuloma
    ÇüÁú¼¼Æ÷À°¾ÆÁ¾
  • plasma hemoglobin
    Ç÷ÀåÇ÷¾×¼Ò
  • plasma iron
    Ç÷Àåö
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • ERPF => effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • ERPF=£¾effective renal plasma flow
    À¯È¿½ÅÇ÷·ù·®.
  • RPF => renal plasma flow
    ½ÅÇ÷Àå·ù(·®)
  • renal plasma flow
    ½ÅÇ÷ÀåÀ¯Åë·®(ãìúìíìêü÷×åÖ).
  • renal plasma flow
    ½ÅÇ÷Àå·ù(·®)
  • TIBC => total iron binding capacity
    ÃÑö°áÇÕ´É
  • TLC => total lung capacity
    ÀüÆó¿ë·®
  • TORP [=total ossicular replacement prosthesis]
    ÀüÀ̼Ұñ´ëÄ¡¹°
  • holoblastic cleavage total cleavage
    ÀüüºÐÇÒ
  • renal blood flow
    ½ÅÇ÷·ù·®
  • renal blood flow =RBF
    ½ÅÇ÷·ù(·®)(ãìúìêüåÖ).
  • renal plasma clearance
    ½ÅÇ÷Àåû¼ÒÀ²(ãìúìíìôèá·ëÒ).
  • ELBF=£¾effective liver blood flow
    À¯È¿¼º °£Ç÷·ù.
  • ELBF=£¾effective liver blood flow
    À¯È¿ °£Ç÷·ù.
  • Flow
    À¯·®(êüÕá), È帧
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total renal plasma flow
    ÃѽÅÇ÷Àå·ù·®(õÅãì úìíìêüåÖ).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • effective renal plasma flow
    À¯È¿½ÅÇ÷ÀåÀ¯Åë·®
  • effective renal plasma flow =ERPF
    À¯È¿½ÅÇ÷Àå·ù·®(êóüùãìúìíì×µÕá).
  • effective renal plasma flow =ERPF
    À¯È¿½ÅÇ÷Àå·ù·®.
  • renal plasma flow
    ½ÅÇ÷Àå·ù(·®)
  • renal plasma flow
    ½ÅÇ÷ÀåÀ¯Åë·®(ãìúìíìêü÷×åÖ).
  • plasma cell orificial mucositis => plasma cell cheilitis
  • total plasma volume
    ÃÑÇ÷Àå·®(õÅúìíìåÖ).
  • total parenteral nutrition, total
    ÃÑüÀû ºñ°æ±¸Àû ¿µ¾ç¼·Ãë
  • total flow
    ÃÑÀ¯·®, ÀüüÀ¯·®(îïô÷êüåÖ).
  • renal plasma clearance
    ½ÅÇ÷Àåû¼ÒÀ²(ãìúìíìôèá·ëÒ).
  • effective renal blood flow
    À¯È¿½ÅÇ÷·ù(·®)
  • effective renal blood flow =ERBF
    À¯È¿½ÅÇ÷·ù·®(êóüùãìúì×µÕá).
  • effective renal blood flow =ERBF
    À¯È¿½ÅÇ÷·ù·®.
  • renal blood flow
    ½ÅÇ÷·ù·®
  • renal blood flow =RBF
    ½ÅÇ÷·ù(·®)(ãìúìêüåÖ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Lymph plasma
    ¸²ÇÁÀå¾×
    [¿¾ ¿ë¾î] ÀÓÆÄÀå¾×
  • Plasma membrane of erythrocyte
    ÀûÇ÷±¸ÇüÁú¸·
    [¿¾ ¿ë¾î] ÀûÇ÷±¸ÇüÁú¸·
  • Blood plasma
    Ç÷Àå
    [¿¾ ¿ë¾î] Ç÷Àå
  • Plasma membrane
    ÇüÁú¸·
    [¿¾ ¿ë¾î] ¼¼Æ÷¸·
  • Plasma cell
    ÇüÁú¼¼Æ÷
    [¿¾ ¿ë¾î] ÇüÁú¼¼Æ÷
  • Total organism duplication
    °³Ã¼Áߺ¹
    [¿¾ ¿ë¾î] °³Ã¼Áߺ¹
  • Total hyperplasia (Macrodactylia)
    Àüü°ú´ÙÇü¼º (Å«¼Õ°¡¶ôÁõ)
    [¿¾ ¿ë¾î] ÀüüÀû°ÅÀÎÁõ
  • Total organ duplication (Double ureter)
    Àüü±â°üÁߺ¹ (°ã¿ä°ü)
    [¿¾ ¿ë¾î] Àüü±â°üÁߺ¹ (°ã¿ä°ü)
  • Holoblastic cleavage [Total cleavage]
    ÀüüºÐÇÒ
    [¿¾ ¿ë¾î] Àü³­ÇÒ
  • Total heart defect
    Àüü½ÉÀå°áÇÔ
    [¿¾ ¿ë¾î] ½ÉÀåÀü°áÇÔ
  • Total abnormal shape
    ÀüüÀÌ»óÇüÅÂ
    [¿¾ ¿ë¾î] ÀüüÀûÀÌ»óÇü
  • Total inversion (Situs inversus)
    ÀüüÀÚ¸®¹Ù²Þ (¿Â³»ÀåÀÚ¸®¹Ù²Þ)
    [¿¾ ¿ë¾î] ÀüüÀû¿ªÀ§
  • Aortic renal ganglia
    ´ëµ¿¸ÆÄáÆÏ½Å°æÀý
    [¿¾ ¿ë¾î] ´ëµ¿¸Æ½Åµ¿¸Æ½Å°æÀý
  • Left renal vein
    ¿ÞÄáÆÏÁ¤¸Æ
    [¿¾ ¿ë¾î] Á½ÅÁ¤¸Æ
  • Minor renal calices
    ÀÛÀº(ÄáÆÏ)¼úÀÜ
    [¿¾ ¿ë¾î] ¼Ò½Å¹è
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • interstitial plasma cell pneumonia
    °£Áú¼ºÇüÁú¼¼Æ÷Æó¿°
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total inhibition
    ÀüÀúÇØ(îïîÁúª)
  • total iron-binding capacity
    ÃÑö°áÇÕ´É (õÅôÑÌ¿ùêÒö)
  • total osmotic pressure
    ÃÑ»ïÅõ¾Ð (õÅß¶÷âäâ)
  • total titer
    ÃÑ¿ª°¡ (õÅæ³Ê¤)
  • renal clearance
    ½ÅûÁ¤(ãìôèïä)
  • renal compensation
    ½Åº¸»ó(ãìÜÍßÁ)
  • renal glucosuria
    ½Å(ãì)±Û·çÄÚ½º´¢(Òã)
  • renal hypertension
    ½Å°íÇ÷¾Ð(ãìÍÔúìäâ)
  • renal threshold
    ½Å(ãì)¹®ÅÎ
  • renal tubular acidosis
    ½Å ´¢°ü »êÁõ(ãìÒãη߫ñø)
  • blood plasma
    Ç÷Àå(úìíì)
  • native plasma
    ÀÚ¿¬(í»æÔ) Çö󽺸¶
  • plasma
    "Ç÷Àå(úìíì), ÇöóÁ"
  • plasma cell
    ÇüÁú¼¼Æ÷(û¡òõá¬øà)
  • plasma clearance
    Ç÷ÀåûÁ¤(úìíìôèïä)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • total
    ÀüüÀÇ, ¿ÏÀüÀÇ
  • total body opacification
    Àü½ÅºÒÅõ¸íÈ­
  • total gain
    ÃѰÔÀÎ
  • plasma
    Ç÷Àå, ÇöóÁ
  • plasma cell
    ÇüÁú¼¼Æ÷
  • plasma cell pneumonia
    ÇüÁú¼¼Æ÷¼ºÆó·Å
  • plasma expander
    ÇöóÁÁõ·®Á¦
  • plasma protein
    Ç÷Àå´Ü¹éÁú
  • plasma substitute
    Ç÷Àå´ë¿ëÁ¦
  • central renal echo complex
    ½ÅÁ߽ɿ¡ÄÚº¹ÇÕü
  • hepato renal echo contrast
    °£½ÅÀå¿¡ÄÚ´ëÁ¶
  • renal
    ÄáÆÏÀÇ, ½ÅÀÇ, ½Å¼ºÀÇ, ½ÅÀåÀÇ
  • renal agenesis
    ½Å¹«¹ßÀ°Áõ
  • renal angiography
    ½ÅÇ÷°üÁ¶¿µ¼ú
  • renal arteriogram
    ½Åµ¿¸ÆÁ¶¿µ»ó
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
TPC thromboplastic plasma component; thyroid papillary carcinoma; total patient care; total plasma catec...
TC target cell; taurocholate; temperature compensation; teratocarcinoma; tertiary cleavage; tetracyclin...
FENa, FeNa Fractional Excretion of Sodium
  ; VolumeÀÇ °³³äÀ» Á¦°ÅÇÏ¿© Á» ´õ Á¤È®ÇÑ ½ÅÀåÀÇ ³óÃà ´É·ÂÀ» Æò°¡,
 &n...
CBF capillary blood flow; cerebral blood flow; ciliary beat frequency; coronary blood flow; cortical blo...
HBF hand blood flow; hemispheric blood flow; hemoglobinuric bilious fever; hepatic blood flow; hypothala...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ERPF Effective Renal Plasma Flow
RPF Renal Plasma Flow
RPF renal plasma flow rate
TRBF Total renal blood flow
ERBF Effective renal blood flow
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • renal plasma flow
    ½Å Ç÷Àå·ù, ½Å Ç÷Àå·ù·®
  • total flow
    ÃÑ À¯·®, Àüü À¯·®
  • renal blood flow
    ½Å Ç÷·ù·®
  • blood plasma substitute
    ´ë¿ë Ç÷Àå
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • malignant plasma cell
    ¾Ç¼º ÇüÁú ¼¼Æ÷
  • pathologic plasma protein
    º´Àû Ç÷Àå ´Ü¹é
  • plasma cell
    ÇüÁú±¸, Ç÷Àå ¼¼Æ÷, ÇüÁú ¼¼Æ÷
    1. Ç×ü¸¦ ºÐºñÇÒ ¼ö ÀÖ´Â ¼¼Æ÷. 2. ¸¸¼º ¿°ÁõÀ̳ª ƯÁ¤ Áúȯ »óÅÂ, ¶Ç´Â Á¾¾ç¿¡¼­ ³ªÅ¸³ª´Â ¼¼Æ÷·Î ¼øÈ¯ Ç÷¾×¿¡ Á¤»óÀûÀ¸·Î ³ªÅ¸³ªÁö´Â ¾Ê´Â´Ù. Å©±â´Â Àӯı¸º¸´Ù Å©¸ç, È£¿°±â¼ºÀÇ ¿°»öÁúÀ» °¡Áö´Â ÇÙÀÌ ¼¼Æ÷ÀÇ Á߽ɿ¡¼­ ¹þ¾î³ª ½Ã°èÀÇ ¼ýÀÚÆÇÀÇ ¼ýÀÚµéó·³ º¯¿¬¿¡ À§Ä¡Çϰí ÀÖ´Ù. ÀÌ ¼¼Æ÷ÀÇ ±â¿ø¿¡ °üÇØ¼­´Â
  • plasma cell dyscrasia
    Ç÷Àå ¼¼Æ÷ ÀÌ»ó
  • plasma cell pneumonia
    ÇüÁú ¼¼Æ÷¼º Æó·Å
  • plasma cloud
    Çö󽺸¶ ±¸¸§
  • plasma cortisol
    Ç÷Àå ÄÚÆ¼Á¹
  • plasma extravasation
    Ç÷Àå À¯Ãâ, Ç÷Àå ÀÏÇ÷
  • plasma formation
    Çö󽺸¶ Çü¼º
  • plasma hemoglobin
    Ç÷Àå Çì¸ð±Û·Îºó, Ç÷Àå Ç÷¾×¼Ò
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
renal plasma flow <physiology> The amount of plasma that perfuses the kidneys per unit time, approximately 10% greater than effective renal plasma flow.
It should be differentiated from the renal blood flow which refers to the total volume of blood flowing through the renal vasculature, while the renal plasma flow refers to the rate of plasma flow.
(12 Dec 1998)
effective renal plasma flow <physiology> The amount of plasma flowing to the parts of the kidney that have a function in the production of constituents of urine; the clearance of substances such as iodopyracet and p-aminohippuric acid, assuming that the extraction ratio in the peritubular capillaries is 100%.
It is the amount of plasma perfusing the kidney tubules per unit time, generally measured by p-aminohippurate clearance. It should be differentiated from renal plasma flow which is approximately 10% greater than the effective renal plasma flow.
(07 Mar 2000)
renal blood flow, effective The amount of blood flowing to the parts of the kidney that are involved with the production of constituents of urine. It is that portion of the total renal blood flow that perfuses functional renal tissue (e.g., the glomeruli). It should be differentiated from renal plasma flow, effective which is based on the amount of plasma rather than on total renal blood.
(12 Dec 1998)
effective renal blood flow The amount of blood flowing to the parts of the kidney that are involved with production of constituents of urine.
(05 Mar 2000)
average flow rate <physiology> The flow rate determined by dividing the total volume passed in a time period divided by the time period, usually quoted in mls per minute.
(05 Mar 2000)
Bingham flow The flow characteristics exhibited by a Bingham plastic.
(05 Mar 2000)
blood flow velocity A value equal to the total volume flow divided by the cross-sectional area of the vascular bed.
(12 Dec 1998)
gene flow The movement of genes from one population to another viainterbreeding.
(09 Oct 1997)
maximal expiratory flow rate <chest medicine, physiology> Measurement of rate of airflow during the first liter expired after the first 200 ml have been exhausted during a forced vital capacity determination. Common abbreviations are MEFR, FEF 202-1200, and fef 0.2-1.2.
Acronym: MEFR
(21 Jun 2000)
maximal expiratory flow-volume curve <chest medicine> Curves depicting maximal expiratory flow in liters/second at each point of lung inflation (expressed in liters or percentage of forced vital capacity) during a forced vital capacity determination. Common abbreviation is mefv.
(12 Dec 1998)
maximal midexpiratory flow rate Measurement of rate of airflow over the middle half of a forced vital capacity determination (from the 25 percent level to the 75 percent level). Common abbreviations are mmfr and fef 25%-75%.
(12 Dec 1998)
peak expiratory flow The maximum flow at the outset of forced expiration, which is reduced in proportion to the severity of airway obstruction, as in asthma.
(05 Mar 2000)
peak expiratory flow rate Measurement of the maximum rate of airflow attained during a forced vital capacity determination. Common abbreviations are pefr and pfr.
(12 Dec 1998)
peak flow <chest medicine, physiology> The maximum flow rate of air breathed out during forced expiration.
(15 Nov 1997)
peak flow rate Maximum urinary flow rate during voiding as measured by a uroflowmeter.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • plasma
    ¿øÇüÁú;Ç÷Àå;Àӯľ×;À¯Àå
  • renal
    ½ÅÀåÀÇ
  • renal
    ½ÅÀåÀÇ;½ÅÀåºÎÀÇ
  • renal calculus
    ½Å°á¼®(kidney stone)
  • renal gland
    ºÎ½Å
  • flow
    ¹ü¶÷ÇÏ´Ù
  • total
    ÀüüÀÇ
  • cash flow
    ij½ÃÇ÷Î(°¨°¡ »ó°¢ºñ¸¦ °¡»êÇÑ ¼øÀÌÀÍ);Çö±Ý À¯ÃâÀÔ;Çö±Ý ÀÚ±Ý
  • energy flow
    (»ýŰèÀÇ)¿¡³ÊÁö È帧
  • flow
    ¸Ó¸®Ä®ÀÌ ´Ã¾îÁö´Ù;(¹Ù¶÷¿¡)¾µ¸®´Ù;(Á¶¼ö°¡)¹Ð´Ù;¸¹ÀÌÀÖ´Ù;È帣°ÔÇÏ´Ù;¹ü¶÷½ÃŰ´Ù;È帧;À¯Ãâ·®;¹Ð¹°;È帣´Ù
  • flow diagram
    ÄÄÇ»ÅÍ ¹®Á¦Ã³¸®¸¦ À§ÇÑ ¼øÀ§Ç¥
  • flow line
    À¯¹®(È­¼º¾Ï À¯µ¿ ¶§¿¡ »ý±â´Â ÁÙ¹«´Ì)
  • flow sheet
    =FLOW DIAGRZM
  • grand total
    ÃѰè
  • total
    Àüü(ÀÇ);ÇÕ°è(ÀÇ);¿ÏÀüÇÑ(a ~ failure)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á